FDA Probes Paclitaxel Devices; Patent Solution; Why Women Pass on the Cath Lab
Interventional cardiology news to note
The FDA is investigating the excess mortality risk linked to paclitaxel-coated balloons and stents in treating peripheral artery disease. The agency recommended monitoring patients who have received such devices, though it said it continues to believe that their benefits outweigh their risks. MedPage Today has the full story here.